Dubai Health Authority (DHA) and its health insurance regulatory body have launched a “first-of-its-kind” digital-led program that is expected to form the foundation for the adoption of value-based healthcare in the emirate, it has been announced.
Unveiled by Saleh Al Hashimi, CEO of Dubai Health Insurance Corporation (DHIC), EJADAH will reportedly “help improve government oversight of the health sector by overseeing clinical, economic and human-centred outcomes.”
He said: “The model is driven by quality outcomes; This will put health consumers at the center of the model, focus on preventive care and reduce health care expenditures thereby achieving health care sustainability.
The analytics-based platform is expected to monitor and evaluate several key performance indicators, which DHA says will “lead to faster claim approval, reduce wastage of healthcare expenditure and focus on preventive care “
why it matters
According to Awad Seghayer Al Ketbi, Director General of the DHA, the authority is “implementing policies and regulations to further accelerate the development of the health sector” while prioritizing “patient centricity.”
“Working with a common vision to advance the health sector in Dubai and establish the emirate as a medical tourism hub,” Al Ketbi said, “the value-based model will further improve health services and preventive care.” Will increase which will lead to better population. Reduction in health and health care expenditure.”
on record
Dr Mohammed Farghali, lead advisor to the DHIC and EJADAH project, explained how a significant portion of the cost of managing non-communicable diseases is dedicated to the management of complications rather than the disease itself.
“By implementing an ecosystem that focuses on preventive care and patient-centered care, this cost can be reduced significantly,” he explained.
The project involves a number of pharmaceutical multinationals who will share expertise, insights and global best practices to help shape the EJADAH programme.
Karim Samy, medical director and head of personalized healthcare services for Roche Pharmaceuticals in the United Arab Emirates (UAE), said: “We believe that value-based healthcare can truly improve patient outcomes as well as healthcare Has the potential to help address sustainability challenges faced by the systems in the region.
“Ejada will work towards ensuring that Dubai’s healthcare sector becomes more sustainable and patient-centric going forward, by encouraging improvement in value rather than volume through alternative payment models. There is no doubt that this will pave the way and inspire other areas in the region to consider similar approaches.
Ahmed Fadl, General Manager of Merck Gulf, said: “Dubai has consistently raised the bar in terms of growth and development by implementing global best practices, which has attracted the attention of global cities. This is a significant project which aims to increase efficiency, efficacy and safety using best practices and methods.
“Both qualitative and quantitative improvements in health care have become critical today, and improvements to the EJADAH program will further enhance quality and address costs while allowing access to next-generation technology.”
